Spyre Therapeutics, Inc. (SYRE) SEC Filings — 2025
11 SEC filings for Spyre Therapeutics, Inc. (SYRE) in 2025.
Filings
- Spyre Narrows Q3 Loss on CVR Revaluation, Asset Sale — 10-Q · Nov 4, 2025
- Spyre Therapeutics Files Material Definitive Agreement 8-K — 8-K · Oct 15, 2025
- Spyre Therapeutics Files 8-K on Financials — 8-K · Oct 14, 2025
- Spyre Therapeutics Narrows Q2 Loss to $33M Amid R&D Focus — 10-Q · Aug 5, 2025
- Spyre Therapeutics Files 8-K — 8-K · Jun 17, 2025
- Spyre Therapeutics Files 8-K on Shareholder Votes and Exhibits — 8-K · Jun 2, 2025
- Spyre Therapeutics Files Q1 2025 10-Q — 10-Q · May 8, 2025
- Spyre Therapeutics Files DEF 14A for Executive Compensation — DEF 14A · Apr 14, 2025
- Spyre Therapeutics Files 8-K on Accountant Change — 8-K · Mar 6, 2025
- Spyre Therapeutics Files 2024 10-K — 10-K · Feb 27, 2025
- Spyre Therapeutics Files 8-K — 8-K · Jan 13, 2025